Procter & Gamble Hygiene and Health Care Limited (PGHH) fundamentals
Procter & Gamble Hygiene and Health Care Limited is a listed company in Personal Products, part of the Fast Moving Consumer Goods sector, listed on the NSE as PGHH (ISIN INE179A01014). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Procter & Gamble Hygiene and Health Care Limited does
Procter & Gamble Hygiene and Health Care Limited is an India-based fast-moving consumer goods (FMCG) company. The Company is engaged in manufacturing and selling branded packaged FMCG in the feminine care and healthcare businesses. The Company has two segments: Health care products and Hygiene products. The Health care products segment comprises ointment and creams, cough drops and tablets. The Hygiene products segment comprises feminine hygiene products and other skin care hygiene products. Its brands include Pampers, Ariel, Tide, Whisper, Gillette, Head & Shoulders, Herbal Essences, Pantene, Ambi Pur, Oral-B, Vicks, Olay, and Old Spice. Its healthcare portfolio includes Vicks VapoRub, Vicks Cough Drops, Vicks Action 500 Advanced, Zzzquil, Vicks Inhaler, Vicks Xtra Strong Rub, Vicks Baby Rub, Vicks VapoRub Steam Pods, Vicks Headache Roll-on and Vicks Cough Syrup. Its Feminine hygiene portfolio includes Whisper Ultra, Whisper Choice, Whisper Ultra Skin Love, among others.
Valuation and market data
| Last close | ₹7518.00 |
|---|---|
| Market capitalisation | ₹24,403 crore |
| Enterprise value | ₹23,961 crore |
| P/E (TTM) | 28.49 |
| Price to book | 32.39 |
| Price to sales (TTM) | 3.20 |
| Book value per share | ₹232.12 |
| Dividend yield | 339.19% |
| Sector | Fast Moving Consumer Goods |
| Industry | Personal Products |
| Listed since | Wed Jul 07 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹4,333 crore | ₹1,167 crore | ₹857 crore | 263.86 |
| Mar 2025 | ₹3,412 crore | ₹862 crore | ₹637 crore | 196.11 |
| Jun 2024 | ₹4,258 crore | ₹939 crore | ₹675 crore | 207.95 |
| Jun 2023 | ₹3,958 crore | ₹839 crore | ₹678 crore | 208.91 |
| Jun 2022 | ₹3,925 crore | ₹790 crore | ₹576 crore | 177.37 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 70.6% |
|---|---|
| Foreign institutions (FII) | 1.0% |
| Mutual funds | 8.0% |
| Other domestic institutions | 7.6% |
| Retail and others | 12.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.